Single-dose nevirapine exposure affects T cell response and cytokine levels in HIV type 1-infected women.
Sharon
S
Shalekoff
Stephen
S
Meddows-Taylor
Diana B
DB
Schramm
Glenda
G
Gray
Gayle
G
Sherman
Ashraf
A
Coovadia
Louise
L
Kuhn
Caroline T
CT
Tiemessen
D000293:Adolescent; D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D018890:Chemoprevention / Q000379:methods*; D016207:Cytokines / Q000378:metabolism*; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology* / Q000517:prevention & control; D006801:Humans; D007231:Infant, Newborn; D019829:Nevirapine / Q000627:therapeutic use*; D011247:Pregnancy; D013601:T-Lymphocytes / Q000276:immunology*; D055815:Young Adult
D019380:Anti-HIV Agents; D016207:Cytokines; D019829:Nevirapine